Medtronic (MDT) Tops Q4 EPS by 3c, Offers FY19 Guidance
Medtronic (NYSE: MDT) reported Q4 EPS of $1.42, $0.03 better than the analyst estimate of $1.39. Revenue for the quarter came in at $8.1 billion versus the consensus estimate of $8 billion.
GUIDANCE:
Medtronic sees FY2019 EPS of $5.10-$5.15, versus the consensus of $5.15.
In fiscal year 2019, the company expects organic revenue growth to be in the range of 4.0 to 4.5 percent.
For earnings history and earnings-related data on Medtronic (MDT) click here.